Renaissance Technologies (RenTech)'s HRMY Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.08 M shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $30.18 M, representing 0.05% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 271,700 shares. Largest reduction occurred in Q3 2023, reducing 118,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,900 | Add 0.64% | 1.08 M | $28.01 |
| Q4 2025 | -66,600 | Reduce 5.86% | 1.07 M | $37.42 |
| Q3 2025 | +207,600 | Add 22.34% | 1.14 M | $27.56 |
| Q2 2025 | +89,100 | Add 10.60% | 929,471 | $31.60 |
| Q1 2025 | +271,700 | Add 47.78% | 840,371 | $33.19 |
| Q4 2024 | +76,071 | Add 15.44% | 568,671 | $34.41 |
| Q3 2024 | -103,200 | Reduce 17.32% | 492,600 | $40.00 |
| Q2 2024 | +215,700 | Add 56.75% | 595,800 | $30.17 |
| Q1 2024 | +121,600 | Add 47.04% | 380,100 | $33.58 |
| Q4 2023 | -33,600 | Reduce 11.50% | 258,500 | $32.30 |
| Q3 2023 | -118,300 | Reduce 28.83% | 292,100 | $32.77 |
| Q2 2023 | -55,400 | Reduce 11.89% | 410,400 | $0.04 |
| Q1 2023 | +123,100 | Add 35.92% | 465,800 | $0.03 |
| Q4 2022 | +17,700 | Add 5.45% | 342,700 | $0.06 |
| Q3 2022 | +33,200 | Add 11.38% | 325,000 | $44.29 |
| Q2 2022 | +149,300 | Add 104.77% | 291,800 | $48.77 |
| Q1 2022 | +7,700 | Add 5.71% | 142,500 | $48.65 |
| Q4 2021 | +95,400 | Add 242.13% | 134,800 | $42.64 |
| Q3 2021 | +27,600 | Add 233.90% | 39,400 | $38.32 |
| Q2 2021 | +11,800 | New Buy | 11,800 | $28.22 |
Renaissance Technologies (RenTech)'s Harmony Biosciences Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q2 2021, acquiring 11,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Harmony Biosciences Holdings, Inc. (HRMY) for 20 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q1 2025, adding 840,371 shares worth $27.89 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,077,371 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $30.18 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.05% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 1,137,071 shares, as reported at the end of Q3 2025.